Issue Price
₹35
Per Share
GMP
NIL
Grey Market
Est. Listing
₹35
Expected Price
Min. Application
₹280,000
2 lots × 4000 shares
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.The company acts as representatives, dealers, agents, stockists, suppliers, traders, and packers.The company serves the pharmaceutical and wellness industries, as well as the FMCG market, offering products like medicines (injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral products), vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items (soaps, sanitizers, baby care), ayurvedic products, cosmetics, food products, dental products, and crude drugs.As of Marc 31, 2025, the company serves over r 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations.The company's distribution network connects with over 170 healthcare product manufacturers, providing access to more than 19,000 SKUs.This product portfolio allows the company to meet customer needs while ensuring quality and reliability in pharmaceutical supply.The company is a pharmaceutical distributor with FDA, FSSAI, and BMC certifications.Competitive Strength:Strengthen its market position by increasing its long-term relationships with its clients.Comprehensive product portfolio.Streamlined supply chain management.Experienced management team with proven execution capabilities.
Vijaypd Ceutical Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 284,000 | — | ₹0.99 Cr | — |
| TOTAL | 5,500,000 | 100.00% | ₹19.25 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹140,000 |
| Retail (Max) | 13 | 52,000 | ₹1,820,000 |
| sNII (Min) | 14 | 56,000 | ₹1,960,000 |
| bNII (Min) | 68 | 272,000 | ₹9,520,000 |
| Particulars | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 107.59 | 54.34 | 50.59 |
| EBITDA | 8.59 | 4.87 | 1.32 |
| Profit After Tax (PAT) | 4.80 | 1.65 | 0.18 |
| Net Worth | 32.17 | 1.00 | 4.93 |
| Total Assets | 57.15 | 33.27 | 32.87 |
| Reserves & Surplus | 18.14 | N/A | N/A |
| Total Borrowings | 21.77 | 30.04 | 25.56 |